Press Releases

Q3 FY2024

14.3% Year on Year Revenue Decrease to £174.4 million

11.8% Revenue Decrease at Constant Currency

Diluted EPS £(0.03) compared to £0.42 in the prior year comparative period

Adjusted diluted EPS £0.22 compared to £0.59 in the prior year comparative period

LONDON--(BUSINESS WIRE)-- Endava plc (NYSE: DAVA) ("Endava" or the "Company"), a leading technology services company combining world-class engineering, industry expertise and a... (continue reading...)

NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Top securities law firm Bleichmar Fonti & Auld LLP announces an investigation into CAE, Inc. (NYSE: CAE) for potential violations of the federal securities laws. If you invested in CAE, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases/cae-inc-investigation or contacting us below.

Why Did CAE Drop 13%?

On May 21, 2024, CAE announced preliminary earnings for Q4 2024 and that it... (continue reading...)

Opening KC2 data center in Shawnee strengthens region's national standing as a tech hub

SHAWNEE, Kan., May 23, 2024 /PRNewswire/ -- Netrality Data Centers, the nation's largest, privately held owner and operator of core interconnection facilities, celebrated the opening of its latest data center facility, KC2-7801 Nieman in Shawnee, Kansas. This state-of-the-art facility is designed to serve as a hub for progressive innovation and support regional economic development... (continue reading...)

#100DaysOfCamping Kicks Off the Summer Camping Season

CHICAGO, May 23, 2024 /PRNewswire/ -- Celebrating 55 years in business, Thousand Trails, a leading campground network that provides travelers the chance to experience top outdoor vacation destinations across North America, is launching its 10th annual #100DaysOfCamping summer campaign. Since 2015, the annual tradition starts Memorial Day weekend, as the contest encourages travelers across the country to get outside... (continue reading...)

NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and inflammatory diseases, today announced that Sandeep Kulkarni, CEO, is expected to participate in the following investor conference:

Jefferies Global Healthcare Conference, New YorkCorporate PresentationThursday, June 6,... (continue reading...)